525 related articles for article (PubMed ID: 26733552)
1. Prostate Cancer, Version 1.2016.
Mohler JL; Armstrong AJ; Bahnson RR; D'Amico AV; Davis BJ; Eastham JA; Enke CA; Farrington TA; Higano CS; Horwitz EM; Hurwitz M; Kane CJ; Kawachi MH; Kuettel M; Lee RJ; Meeks JJ; Penson DF; Plimack ER; Pow-Sang JM; Raben D; Richey S; Roach M; Rosenfeld S; Schaeffer E; Skolarus TA; Small EJ; Sonpavde G; Srinivas S; Strope SA; Tward J; Shead DA; Freedman-Cass DA
J Natl Compr Canc Netw; 2016 Jan; 14(1):19-30. PubMed ID: 26733552
[TBL] [Abstract][Full Text] [Related]
2. NCCN Guidelines Insights: Prostate Cancer, Version 1.2021.
Schaeffer E; Srinivas S; Antonarakis ES; Armstrong AJ; Bekelman JE; Cheng H; D'Amico AV; Davis BJ; Desai N; Dorff T; Eastham JA; Farrington TA; Gao X; Horwitz EM; Ippolito JE; Kuettel MR; Lang JM; McKay R; McKenney J; Netto G; Penson DF; Pow-Sang JM; Reiter R; Richey S; Roach Iii M; Rosenfeld S; Shabsigh A; Spratt DE; Teply BA; Tward J; Shead DA; Freedman-Cass DA
J Natl Compr Canc Netw; 2021 Feb; 19(2):134-143. PubMed ID: 33545689
[TBL] [Abstract][Full Text] [Related]
3. NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.
Schaeffer EM; Srinivas S; Adra N; An Y; Barocas D; Bitting R; Bryce A; Chapin B; Cheng HH; D'Amico AV; Desai N; Dorff T; Eastham JA; Farrington TA; Gao X; Gupta S; Guzzo T; Ippolito JE; Kuettel MR; Lang JM; Lotan T; McKay RR; Morgan T; Netto G; Pow-Sang JM; Reiter R; Roach M; Robin T; Rosenfeld S; Shabsigh A; Spratt D; Teply BA; Tward J; Valicenti R; Wong JK; Berardi RA; Shead DA; Freedman-Cass DA
J Natl Compr Canc Netw; 2022 Dec; 20(12):1288-1298. PubMed ID: 36509074
[TBL] [Abstract][Full Text] [Related]
4. Prostate Cancer, Version 3.2024.
Schaeffer EM; Srinivas S; Adra N; An Y; Bitting R; Chapin B; Cheng HH; D'Amico AV; Desai N; Dorff T; Eastham JA; Farrington TA; Gao X; Gupta S; Guzzo T; Ippolito JE; Karnes RJ; Kuettel MR; Lang JM; Lotan T; McKay RR; Morgan T; Pow-Sang JM; Reiter R; Roach M; Robin T; Rosenfeld S; Shabsigh A; Spratt D; Szmulewitz R; Teply BA; Tward J; Valicenti R; Wong JK; Snedeker J; Freedman-Cass DA
J Natl Compr Canc Netw; 2024 Apr; 22(3):140-150. PubMed ID: 38626801
[TBL] [Abstract][Full Text] [Related]
5. Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
Mohler JL; Antonarakis ES; Armstrong AJ; D'Amico AV; Davis BJ; Dorff T; Eastham JA; Enke CA; Farrington TA; Higano CS; Horwitz EM; Hurwitz M; Ippolito JE; Kane CJ; Kuettel MR; Lang JM; McKenney J; Netto G; Penson DF; Plimack ER; Pow-Sang JM; Pugh TJ; Richey S; Roach M; Rosenfeld S; Schaeffer E; Shabsigh A; Small EJ; Spratt DE; Srinivas S; Tward J; Shead DA; Freedman-Cass DA
J Natl Compr Canc Netw; 2019 May; 17(5):479-505. PubMed ID: 31085757
[TBL] [Abstract][Full Text] [Related]
6. NCCN Guidelines Updates: Management of Prostate Cancer.
Mohler JL; Antonarakis ES
J Natl Compr Canc Netw; 2019 May; 17(5.5):583-586. PubMed ID: 31117038
[TBL] [Abstract][Full Text] [Related]
7. NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.
Carroll PR; Parsons JK; Andriole G; Bahnson RR; Castle EP; Catalona WJ; Dahl DM; Davis JW; Epstein JI; Etzioni RB; Farrington T; Hemstreet GP; Kawachi MH; Kim S; Lange PH; Loughlin KR; Lowrance W; Maroni P; Mohler J; Morgan TM; Moses KA; Nadler RB; Poch M; Scales C; Shaneyfelt TM; Smaldone MC; Sonn G; Sprenkle P; Vickers AJ; Wake R; Shead DA; Freedman-Cass DA
J Natl Compr Canc Netw; 2016 May; 14(5):509-19. PubMed ID: 27160230
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines.
Mohler JL; Armstrong AJ; Bahnson RR; Boston B; Busby JE; D'Amico AV; Eastham JA; Enke CA; Farrington T; Higano CS; Horwitz EM; Kantoff PW; Kawachi MH; Kuettel M; Lee RJ; MacVicar GR; Malcolm AW; Miller D; Plimack ER; Pow-Sang JM; Roach M; Rohren E; Rosenfeld S; Srinivas S; Strope SA; Tward J; Twardowski P; Walsh PC; Ho M; Shead DA
J Natl Compr Canc Netw; 2012 Sep; 10(9):1081-7. PubMed ID: 22956807
[TBL] [Abstract][Full Text] [Related]
9. Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines.
Benson AB; Bekaii-Saab T; Chan E; Chen YJ; Choti MA; Cooper HS; Engstrom PF; Enzinger PC; Fakih MG; Fenton MJ; Fuchs CS; Grem JL; Hunt S; Kamel A; Leong LA; Lin E; May KS; Mulcahy MF; Murphy K; Rohren E; Ryan DP; Saltz L; Sharma S; Shibata D; Skibber JM; Small W; Sofocleous CT; Venook AP; Willett CG; Gregory KM; Freedman-Cass DA;
J Natl Compr Canc Netw; 2013 May; 11(5):519-28. PubMed ID: 23667203
[TBL] [Abstract][Full Text] [Related]
10. Current management of advanced and castration resistant prostate cancer.
Gomella LG; Petrylak DP; Shayegan B
Can J Urol; 2014 Apr; 21(2 Supp 1):1-6. PubMed ID: 24775717
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer, version 1.2014.
Mohler JL; Kantoff PW; Armstrong AJ; Bahnson RR; Cohen M; D'Amico AV; Eastham JA; Enke CA; Farrington TA; Higano CS; Horwitz EM; Kawachi MH; Kuettel M; Lee RJ; Macvicar GR; Malcolm AW; Miller D; Plimack ER; Pow-Sang JM; Richey S; Roach M; Rohren E; Rosenfeld S; Small EJ; Srinivas S; Stein C; Strope SA; Tward J; Walsh PC; Shead DA; Ho M;
J Natl Compr Canc Netw; 2013 Dec; 11(12):1471-9. PubMed ID: 24335682
[TBL] [Abstract][Full Text] [Related]
12. Modification and implementation of NCCN guidelines on prostate cancer in the Middle East and North Africa region.
Hassen WA; Karsan FA; Abbas F; Beduk Y; El-Khodary A; Ghosn M; Khader J; Khauli R; Rabah DM; Shamseddine A; Srinivas S;
J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S26-8. PubMed ID: 20697128
[TBL] [Abstract][Full Text] [Related]
13. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline.
Loblaw DA; Virgo KS; Nam R; Somerfield MR; Ben-Josef E; Mendelson DS; Middleton R; Sharp SA; Smith TJ; Talcott J; Taplin M; Vogelzang NJ; Wade JL; Bennett CL; Scher HI;
J Clin Oncol; 2007 Apr; 25(12):1596-605. PubMed ID: 17404365
[TBL] [Abstract][Full Text] [Related]
14. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].
Mottet N; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Schmid HP; van der Kwast T; Wiegel T; Zattoni F; Heidenreich A
Actas Urol Esp; 2011; 35(10):565-79. PubMed ID: 21757258
[TBL] [Abstract][Full Text] [Related]
15. Screening, risk assessment, and the approach to therapy in patients with prostate cancer.
Freedland SJ
Cancer; 2011 Mar; 117(6):1123-35. PubMed ID: 20960523
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology, diagnosis and treatment of prostate cancer.
Newman J
Radiol Technol; 1996; 68(1):39-64; quiz 65-8. PubMed ID: 8880970
[TBL] [Abstract][Full Text] [Related]
17. Active Surveillance as Initial Management of Newly Diagnosed Prostate Cancer: Data from the PURC.
Botejue M; Abbott D; Danella J; Fonshell C; Ginzburg S; Guzzo TJ; Lanchoney T; Marlowe B; Raman JD; Smaldone M; Tomaszewski JJ; Trabulsi EJ; Uzzo RG; Reese AC
J Urol; 2019 May; 201(5):929-936. PubMed ID: 30720692
[TBL] [Abstract][Full Text] [Related]
18. [Advanced Prostate Cancer Consensus Conference 2017 : Discussion of the recommendations for diagnosis and treatment of metastatic prostate cancer by a German panel of experts].
Schostak M; König F; Bögemann M; Goebell P; Hammerer P; Machtens S; Schwentner C; Thomas C; von Amsberg G; von Rundstedt FC; Heidenreich A
Urologe A; 2018 Jul; 57(7):813-820. PubMed ID: 29808368
[TBL] [Abstract][Full Text] [Related]
19. Disease and Treatment Characteristics of Men Diagnosed With Metastatic Hormone-Sensitive Prostate Cancer in Real Life: Analysis From a Commercial Claims Database.
Flaig TW; Potluri RC; Ng Y; Todd MB; Mehra M; Higano CS
Clin Genitourin Cancer; 2017 Apr; 15(2):273-279.e1. PubMed ID: 27876504
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of prostate cancer.
Hernandez J; Thompson IM
Med Clin North Am; 2004 Mar; 88(2):267-79, ix. PubMed ID: 15049578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
